← back to search

Li Xuan

Southern Medical University · CN
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, and Acute Lymphoblastic Leukemia research.
h-index
32
citations
3,817
works
288
NIH funding
primary concept
Medicine
email

Recent publications

Activation of IL-2/IL-2R pathway by Hedyotis diffusa polysaccharide improves immunotherapy in colorectal cancer
International Journal of Biological Macromolecules 2025cited by 8position: middledoi
Chinese expert consensus on shape-sensing robotic-assisted bronchoscopy (ssRAB) in the management of peripheral pulmonary lesions
Translational Lung Cancer Research 2025cited by 3position: middledoi
Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study
British Journal of Haematology 2025cited by 3position: middledoi
Urea functions as a risk signal driving astrocyte-mediated neuroinflammation following stroke
Journal of Neuroinflammation 2025cited by 2position: middledoi
Potential distribution changes of Xanthium italicum under environmental change scenarios
2025cited by 0position: middledoi
Coxsackievirus group B3 regulates ASS1-mediated metabolic reprogramming and promotes macrophage inflammatory polarization in viral myocarditis
Journal of Virology 2024cited by 6position: middledoi
Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial
Journal of Hematology & Oncology 2023cited by 68position: middledoi
Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial
The Lancet Haematology 2023cited by 66position: firstdoi
Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial
Journal of Hematology & Oncology 2022cited by 91position: middledoi
Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial
Journal of Clinical Oncology 2022cited by 51position: middledoi
Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial
The Lancet Oncology 2020cited by 313position: firstdoi
Preparation, morphology, and properties of conducting polyaniline‐grafted multiwalled carbon nanotubes/epoxy composites
Journal of Applied Polymer Science 2012cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Qifa Liu · University of Science and Technology of China6 papers (2020–2025)Fen Huang · Sun Yat-sen University6 papers (2020–2025)Zhiping Fan · China-Japan Friendship Hospital6 papers (2020–2025)Ren Lin · Xiangya Hospital Central South University5 papers (2020–2023)Lan Deng · Tianjin Agricultural University5 papers (2020–2023)Na Xu · Tongji Hospital5 papers (2020–2023)Xinquan Liang · Shandong Provincial QianFoShan Hospital5 papers (2020–2025)Dongjun Lin · Sun Yat-sen University4 papers (2022–2025)Pengcheng Shi · Chinese PLA General Hospital4 papers (2020–2023)Xiaodan Luo · Army Medical University3 papers (2020–2023)Yu Wang · Affiliated Hospital of Liaoning University of Traditional Chinese Medicine3 papers (2020–2023)Jing Sun · Jiangnan University3 papers (2020–2023)Hua Jin · Nathan Kline Institute for Psychiatric Research3 papers (2022–2025)Yajing Xu · South China University of Technology3 papers (2020–2023)Ruoyang Shao · Southern Medical University2 papers (2023–2023)Jie Xiao · South China Agricultural University2 papers (2023–2025)Sanfang Tu · Zhujiang Hospital2 papers (2020–2023)Min Dai · Nanchang University2 papers (2023–2025)Xiao‐Jun Huang · Lanzhou University2 papers (2020–2023)Shunqing Wang · Guangzhou First People's Hospital2 papers (2022–2022)